PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis

02 May 2025 08:00:00 By Nasdaq GlobeNewswire

Pacira to Report First Quarter 2025 Financial Results on Thursday May 8, 2025

29 Apr 2025 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Two-Year Efficacy Data Following a Single Local Administration of PCRX-201 in Patients with Mild to Severe Osteoarthritis of the Knee

28 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee

22 Apr 2025 16:01:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reaffirms Commitment to Enhancing Value for All Shareholders

17 Apr 2025 17:00:44 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL

07 Apr 2025 16:30:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee

03 Apr 2025 08:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

01 Apr 2025 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Confirms Receipt of Director Nominations from DOMA Perpetual

14 Mar 2025 16:05:42 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 Mar 2025 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results

27 Feb 2025 16:05:01 By Nasdaq GlobeNewswire

Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio

27 Feb 2025 16:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March

26 Feb 2025 08:00:01 By Nasdaq GlobeNewswire

Pacira to Report 2024 Financial Results on Thursday February 27, 2025

20 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

Pacira Announces Updates to Board of Directors

30 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments

21 Jan 2025 08:00:01 By Nasdaq GlobeNewswire

Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization

10 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Receives FDA 510k Clearance for New iovera° SmartTip to Manage Chronic Low Back Pain via Long-lasting Medial Branch Nerve Block

07 Jan 2025 08:00:00 By Nasdaq GlobeNewswire